Delivery Order SPE2DB20D1109-SPE2DB23FP29S

Award Date 6/8/23
Potential Completion Date 6/9/23
Potential Value $9.3K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $7,677.94 for the supply of Trulicity 1.5 mg/0.5 ml pens. The contract was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense, and has a completion date of April 8, 2022. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary...
This contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $13,442.44 for the pharmaceutical product Trulicity 0.75 mg/0.5 ml pen. The award was made by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense, and has a completion date of January 26, 2024. This order is placed under Amerisourcebergen's existing $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Trulicity 1.5 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The contract, valued at $1,451.40, is a firm fixed-price delivery order with an ultimate completion date of April 16, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $10,478.84 for the supply of Trulicity 0.75 mg/0.5 ml pens. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of January 19, 2024. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $1,741.68 for the supply of Trulicity 3 mg/0.5 ml pens. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of August 29, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Trulicity 0.75 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The contract has a ceiling value of $7,343.56 and an ultimate completion date of May 7, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award is for the delivery of Trulicity 4.5 mg/0.5 ml pens to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,856.39 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of September 19, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $1,331.22 for the pharmaceutical product Trulicity 0.75 mg/0.5 ml pen. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of March 8, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Trulicity 0.75 mg/0.5 ml pen 0.5 ml. The contract, valued at $15,009.96, is a firm fixed-price delivery order with a completion date of January 18, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,977.42 for the supply of Trulicity 0.75 mg/0.5 ml pen 0.5 ml. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, with a completion date of January 2, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB23FP29S
    Delivery Order

This contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., covers the delivery of Trulicity 0.75 mg/0.5 ml pens to the Defense Logistics Agency (DLA) Troop Support Medical. The firm-fixed-price delivery order, valued at $9,311.44, has a completion date of June 9, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition. This contract demonstrates Amerisourcebergen's role as a critical supplier of essential medications and medical commodities to the U.S. Department of Defense and its healthcare facilities.

Generated 2/27/25, 11:58 AM